Vectorite Biomedical Inc.

Vectorite Biomedical Inc. is a biotechnology company specializing in the research, development, and production of cell-based biomedical products and services. The company focuses on immune cell preparation, offering manufacturing services and solutions for the collection, processing, and storage of immune cells. Its core product offerings include cell preparation products and services relevant to the treatment of infectious diseases, inflammatory conditions, cancer, and tumor-related illnesses. Additionally, Vectorite Biomedical provides proprietary services such as dendritic cell (DC) vaccines and natural killer (NK) cell therapies, supporting advances in cellular immunotherapy. Established in 1993 and headquartered in New Taipei City, the company operates primarily within Taiwan but also serves international markets. Operating within the healthcare sector—specifically in the biotechnology and pharmaceutical segments—Vectorite Biomedical plays an important role in supplying advanced biotechnological solutions for both clinical and research applications, addressing pressing needs in precision medicine and the broader biomedical industry.